NIYATILEAS

Veerhealth Care Share Price

 

 

Start SIP in NIYATILEAS

Start SIP

Performance

  • Low
  • ₹19
  • High
  • ₹20
  • 52 Week Low
  • ₹9
  • 52 Week High
  • ₹24
  • Open Price₹20
  • Previous Close₹19
  • Volume6,197

Investment Returns

  • Over 1 Month + 2.17%
  • Over 3 Month + 7.05%
  • Over 6 Month + 4.16%
  • Over 1 Year -1.18%

Smart Investing Starts Here Start SIP with Veerhealth Care for Steady Growth!

Invest Now

Veerhealth Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 83.1
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 39
  • P/B Ratio
  • 1.7
  • Average True Range
  • 0.95
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.08
  • RSI
  • 60.69
  • MFI
  • 83.49

Veerhealth Care Financials

Veerhealth Care Technicals

EMA & SMA

Current Price
₹19.29
-0.04 (-0.21%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹18.66
  • 50 Day
  • ₹18.55
  • 100 Day
  • ₹18.53
  • 200 Day
  • ₹18.45

Resistance and Support

19.16 Pivot Speed
  • R3 20.52
  • R2 20.01
  • R1 19.67
  • S1 18.82
  • S2 18.31
  • S3 17.97

Veerhealth Care Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-12 Quarterly Results
2025-08-12 Quarterly Results & A.G.M.
2025-05-30 Audited Results & Final Dividend
2025-02-12 Quarterly Results
2024-11-14 Quarterly Results
Date Purpose Remarks
2023-09-22 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.

Veerhealth Care F&O

Veerhealth Care Shareholding Pattern

No data available.

Veerhealth Care FAQs

Veerhealth Care share price is ₹19 As on 01 January, 2026 | 13:14

The Market Cap of Veerhealth Care is ₹38.6 Cr As on 01 January, 2026 | 13:14

The P/E ratio of Veerhealth Care is 83.1 As on 01 January, 2026 | 13:14

The PB ratio of Veerhealth Care is 1.7 As on 01 January, 2026 | 13:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23